Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2013
Headcount
1-10
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Adastroderm is focused on dermatology, developing a medical device targeted to improve early stage diagnosis of malignant melanoma. The company develops a healthy aging Pharma drug in a P2 clinical stage, as well.
Q&A
- What is Adastroderm's primary focus?
- Adastroderm is focused on dermatology, developing a medical device for early-stage diagnosis of malignant melanoma and a healthy aging Pharma drug in P2 clinical stage.
- When was Adastroderm founded?
- Adastroderm was founded in January 2013.
- What is Adastroderm's current status?
- Adastroderm is currently inactive as of April 2016.
- Where is Adastroderm headquartered?
- Adastroderm is headquartered in Tel Aviv-Yafo, Center District, Israel.
- What is the employee count for Adastroderm?
- Adastroderm has 1-10 employees.
- What is Adastroderm's current funding stage?
- Adastroderm is in the Pre-Funding stage.
- What sector does Adastroderm primarily operate in?
- Adastroderm's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Tags
early-detectioncancermedical-devicesoncologydrug-developmentdermatology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2013-1 |
|---|---|
| Status reason | Non Active, Apr 2016 |